ZETA SURGICAL

Next-Generation Surgical Navigation and Robotics

zetasurgical.com

HQ: Boston, MA, USA

11-50

Healthcare

Company research

Public company, workplace, funding, and market signals

Updated Aug 2, 2026

Overview

ZETA SURGICAL (formerly Z Imaging) is a Boston-based private medical-device and digital-surgery company founded in 2018. It develops frameless, AI-powered neuronavigation and robotic platforms intended to bring precise image guidance beyond the traditional operating room, including ambulatory, emergency, interventional, and mental-health settings.

Primary product

The Zeta platform: the FDA-cleared Zeta Navigation System with Zeta Stylet and Zeta Bolt for image-guided neurosurgical procedures, plus the Zeta TMS Navigation/Robotic System for precision-guided transcranial magnetic stimulation.

Founded

2018

Headquarters

Boston, Massachusetts, United States

Team size

1–10 publicly reported; YC lists team size 12

Industry

Medical equipment manufacturing

Sub-industry

Neurosurgical navigation, medical robotics, digital surgery, and neuromodulation

Offices

280 Summer Street, Floor 7, Boston, MA 02210, United States

2 Park Plaza, Boston, MA 02116, United States

Business model

B2B medical-device sales and deployment to hospitals, surgery centers, and specialty clinics

Commercial deployment and partnerships with clinical providers

Hardware-plus-software surgical navigation platform

Potential procedure-specific instruments and accessories

Funding

Stage

Seed / early commercial-stage private company

Total raised

$8.5M

Latest round

Seed VC - IV · Nov 2023

Latest amount

$1.1M

Later Stage VC

Jan 2025

$8.9M

Seed VC - IV

Nov 2023 · Innospark Ventures

$1.1M

Preferred Stock Financing

Nov 2023

Pre-seed

Mar 2022

$250K

Seed financing

Mar 2022 · Innospark Ventures

$5.2M

Debt

Mar 2022

$500K

Seed

Jan 2022

$1.5M

Seed / YC and Plug and Play pre-seed

Aug 2019 · Y Combinator / Plug and Play Tech Center

$250K

Seed / accelerator funding

May 2017 · MassChallenge

People & investors

Leadership

Jose Maria Amich

Co-Founder and CEO

Raahil Sha

Co-Founder and CTO

William Gormley

Co-Founder and Chief Medical Officer

Hieu Le Mau

Chief Operating Officer; Director of Operations

Benjamin H. Lee

Chief Product Officer

Vincent Lan

Chief Business Officer and General Counsel

Matthew McGirt

Chief Strategy Officer

Investors

Artesian VC

Artesian Venture Partners

Brinc

Emles Advisors

Emles Venture Partners

George Bickerstaff

Innospark Ventures

MassChallenge

Particle Accelerator Investment Limited

Plug and Play Tech Center

Plug and Play Ventures

Reinforced Ventures

Trevor Fetter

TSV Capital (Los Altos)

Work & culture

The company describes itself as a multidisciplinary team of engineers, scientists, designers, operators, and clinicians. Public hiring material emphasizes mission-driven work, rapid product development, clinical collaboration, and improving surgical accuracy, safety, and accessibility.

Compensation

A public Operations Associate listing showed $50,000–$85,000. Public internship listings indicated paid stipends, with third-party reposts showing approximately $3,500–$5,000 for a listed internship period. H-1B labor-condition data reports two filings since FY2022, including one FY2025 filing at $150,000 and one FY2022 filing at $85,000; this is not proof of a general sponsorship policy.

Benefits

Paid internship/stipend reported for engineering internships

Mentorship from experienced engineers and clinical advisors

Ownership of medical-device projects

Exposure to the full product-development lifecycle

Letter of recommendation for qualifying interns

Product & market

Pricing

Not publicly disclosed; appears to be enterprise medical-device deployment and/or sale plus procedure-specific instruments/accessories.

Differentiators

—Frameless and markerless navigation without cranial pins or rigid head fixation
—Real-time tracking of patient movement at high frequency with sub-millimeter accuracy claims
—Compact, mobile system designed for rapid deployment beyond the OR
—AI and computer vision alignment of preoperative CT/MRI with patient anatomy
—Coverage across neurosurgery, emergency/bedside procedures, ambulatory surgery, and TMS
—FDA-cleared cranial-navigation instruments and TMS robotic navigation
—RealTrack technology dynamically maintains TMS-coil targeting during treatment

Technology

Artificial intelligence

Computer vision

Real-time markerless patient and instrument tracking

RealTrack technology

CT/MRI-to-anatomy image alignment

Sub-millimeter navigation

Robotic positioning for TMS coils

Mixed-reality visualization

Proprietary surgical instruments

Doosan robotic-arm integration in the earlier platform

Customers

HOPE Therapeutics / NRx Pharmaceuticals-affiliated clinics, including a first commercial TMS deployment

Clinical collaborators and research sites including Singapore General Hospital / National Neuroscience Institute (trial context, not necessarily paying customers)

Planned Big Ten Neurosurgical Consortium commercial pilot (planned, not confirmed as completed)

Competitors

Medtronic

Brainlab

ClearPoint Neuro

Scale & contact

Estimated revenue

Approximately $1M–$10M; third-party estimates range from about $2M to $4.3M annually and should be treated as directional, not audited.

Estimated monthly visits

2.7K

Traffic estimate as of Aug 2026

legal@zetasurgical.com 857-272-5703

Latest news

Zeta TMS Robotic System Receives FDA 510(k) Clearance

ZETA SURGICAL · Jul 2026

The company announced FDA 510(k) clearance for its robotic TMS system, which dynamically tracks patient movement and adjusts coil positioning with sub-millimeter-level accuracy.

ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics

Investing News Network / PR Newswire · Jun 2026

Partnership/commercial milestone: first patient treatment using the Zeta TMS Navigation System at a HOPE Therapeutics clinic in Sarasota; HOPE had installed systems in Sarasota and West Palm Beach.

Zeta Surgical and HOPE Therapeutics Announce First Patient Treatment

ZETA SURGICAL · Jun 2026

The companies announced the first patient treatment with the FDA-cleared Zeta TMS Navigation System at a HOPE Therapeutics clinic in Sarasota.

Zeta Surgical receives FDA 510(k) clearance expanding access to brain tumor biopsies, hydrocephalus, and trigeminal neuralgia

Zeta Surgical / PR Newswire · May 2026

Regulatory milestone: FDA clearance for the Zeta Navigation System, Zeta Stylet and Zeta Bolt; company said it planned a commercial pilot with the Big 10 Neurosurgical Consortium.

Zeta Surgical Receives FDA 510(k) Clearance Expanding Access to Brain Tumor Biopsies, Hydrocephalus, and Trigeminal Neuralgia

PR Newswire / ZETA SURGICAL · May 2026

FDA cleared the Zeta Navigation System together with the Zeta Stylet and Zeta Bolt for several neurosurgical applications; the company cited a 15-patient first-in-human ventriculostomy study and a planned large commercial pilot.

Jobs and careers at ZETA SURGICAL

21 jobs at ZETA SURGICAL

Product Manager I

On-site

Meridian

Bangalore - EC

Today

On-site

Full-time